News Room
Arrowhead Remains Well-Positioned For RNAi-Based Therapeutic Breakthroughs (NASDAQ:ARWR)
Introduction Arrowhead Pharmaceuticals (NASDAQ:ARWR) is a clinical-stage biotechnology company that harnesses RNA interference to develop treatments for difficult diseases by…
South Africa’s former president Jacob Zuma pardoned after ‘special remission’
Receive free South African politics updatesWe’ll send you a myFT Daily Digest email rounding up the latest South African politics…
The Inflation Numbers Were Good. Why the Fed Still Won’t Be Happy.
The inflation rate in July came in slightly lower than expected. That gives the Federal Reserve a little less reason…
Ford, GM Stocks Tank. It Has to Do With Car Prices.
Rising prices for new and used cars have been a thorn in the sides of U.S. consumers for years. New…
EVs, self-driving cars and how to make money from them in the stock market
Coverage of the electric-vehicle space is typically focused on battery EVs. Maybe plug-in hybrids are boring, or maybe people shy…
US Supreme Court Challenges Purdue’s Opioid Settlement
© Reuters. US Supreme Court Challenges Purdue’s Opioid Settlement The US Supreme Court has decided to assess Purdue Pharma's $6…
Another Rare Macroeconomic Bird Sighted? The Dreaded Bear Steepener
In my last missive (The Stock Market Loves Bidenomics (So Far) (forbes.com)), we pointed out a rare policy called “fiscal…
Here’s Why We Think ResMed Stock Is Undervalued After An 18% Fall In A Month
ResMed (NYSE: RMD), a medical equipment company, has seen an 18% fall in a month, underperforming the broader S&P500 index,…